Spry Review

Spry: a weight-loss and longevity bundle under one roof

Spry isn't trying to be the cheapest semaglutide script online — it's pitching a lifestyle. Alongside compounded semaglutide and tirzepatide, it sells three anti-aging peptides (BPC-157, NAD+, and sermorelin) on the same membership, with the tagline 'Your best body.' If you're someone who already buys into the longevity-and-optimization world and wants your GLP-1 to live next to your peptides, Spry is built for you. If you only want weight loss and nothing else, you're paying for a menu you won't use — and there are a few transparency gaps worth knowing before you sign up.

How the pricing actually works

Spry keeps it refreshingly simple and puts the numbers right on the homepage — no full sign-up wall to see what you'll pay. Compounded semaglutide starts at $199 a month and tirzepatide starts higher, in the high-two-hundreds. Those are 'starting at' prices tied to the introductory dose, so expect your cost to climb as you titrate up — Spry doesn't publish the full dose ladder, so the early number is a floor, not a guarantee. There's no separate membership fee bolted on top, and no teaser first-month rate that resets later; the price you see is the recurring price. For context, the category median across providers we track sits around $170, so Spry's semaglutide lands modestly above the middle of the pack — you're paying a small premium for the broader product shelf.

The three peptides are priced separately in the same ballpark — roughly the high-two-hundreds each — and are billed as add-ons, not part of the GLP-1 plan. Stacking a peptide onto your weight-loss subscription can push your monthly spend well past what a single-drug provider would charge, so go in with eyes open about the total.

The medications — and one honest caveat about the peptides

On the weight-loss side you get the two molecules that matter most right now: compounded semaglutide (the active ingredient in Ozempic and Wegovy) and compounded tirzepatide (the one in Mounjaro and Zepbound). Both are made by a compounding pharmacy rather than the brand manufacturer, which is how the price stays where it is.

The anti-aging trio is where Spry's personality shows. NAD+ and sermorelin have an established following in the longevity space, but BPC-157 deserves a flag: it's an unregulated peptide with limited human efficacy data, and its inclusion reflects a functional-medicine slant more than a settled evidence base. None of this affects your GLP-1 results — just don't read the peptide menu as medical endorsement of every item on it.

• Compounded semaglutide — starts at $199/mo at the introductory dose
• Compounded tirzepatide — starts in the high-two-hundreds/mo
• Anti-aging add-ons — BPC-157, NAD+, and sermorelin, each priced separately
• No insurance accepted — Spry will provide a document to help you self-submit a claim, but it bills cash only

What genuinely sets Spry apart

Two things. First, the combined weight-loss-plus-longevity catalog under one login is unusual — most GLP-1 telehealth shops stay in their lane, and Spry deliberately doesn't. Second, its founder transparency is better than average: it names three co-founders outright (Gabriel Mullins, Sara Yoder, and Tyler Bowman) rather than hiding behind a faceless brand. It's also LegitScript Certified with a public verification link in the footer, no contracts or commitment, and a nurse practitioner who reviews your intake within 24 hours. For a cash-pay compounding platform, those are real positive signals.

Where Spry falls short on disclosure

This is the part to read twice. Spry's homepage displays an 'FDA Approved' badge — but compounded semaglutide and tirzepatide are NOT FDA-approved finished drug products, and the homepage is missing the verbatim 'compounded medications are not FDA-approved' disclaimer that we expect from a provider handling these meds. That framing is potentially misleading, and it's the single biggest mark against Spry. A few other blanks compound it: the pharmacy partner isn't named and its 503A-vs-503B status isn't stated, the list of states served isn't published, the corporate legal entity isn't disclosed, and the co-founders' clinical credentials aren't spelled out. Your intake is also reviewed by a nurse practitioner rather than an MD — fine for many patients, but worth knowing.

Who should choose Spry

• Longevity and optimization buyers who want a GLP-1 and peptides managed in one place
• People who value seeing pricing and named founders upfront, without a sign-up wall
• Cash-pay patients comfortable self-submitting any insurance claims
• Shoppers who want both semaglutide and tirzepatide options from the same provider

Who should skip it

• Anyone who wants the lowest possible semaglutide price — Spry sits above the category median
• Buyers who want a named pharmacy, a confirmed 503A/503B designation, and a published states list before committing
• Patients who specifically want MD oversight rather than nurse-practitioner review
• Anyone uneasy about an 'FDA Approved' badge on compounded medications without a counterbalancing disclaimer

The bottom line

Spry is a credible, transparent-on-the-surface option for the specific buyer it's built for: someone who wants weight loss and anti-aging peptides bundled together and is happy to pay a small premium for that convenience. The named founders, public pricing, LegitScript certification, and 24-hour review are genuine pluses. But the 'FDA Approved' badge over compounded drugs, the unnamed pharmacy, and the undisclosed states served keep our confidence at medium — solid, not airtight. If the bundle is the draw, Spry earns a look; if you just want the cheapest, cleanest GLP-1 script, compare it against lower-priced single-drug providers using our scoring methodology first.

If you're weighing alternatives, RNK Health ($197/month) and Breeze Meds ($199/month) are among the closest options we track to Spry.